153 related articles for article (PubMed ID: 9122220)
21. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
Sumi T; Fujimoto Y; Nakatsuji N; Suemori H
Stem Cells; 2004; 22(5):861-72. PubMed ID: 15342949
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
23. Acquiring signalling specificity from the cytokine receptor gp130.
Ernst M; Jenkins BJ
Trends Genet; 2004 Jan; 20(1):23-32. PubMed ID: 14698616
[TBL] [Abstract][Full Text] [Related]
24. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells.
Matsuda T; Nakamura T; Nakao K; Arai T; Katsuki M; Heike T; Yokota T
EMBO J; 1999 Aug; 18(15):4261-9. PubMed ID: 10428964
[TBL] [Abstract][Full Text] [Related]
25. alpha-thrombin inhibits interleukin-6-induced Stat3 signaling and gp130 gene expression in primary cultures of human lung fibroblasts.
Bhat GJ; Raghu G; Gunaje JJ; Idell S
Biochem Biophys Res Commun; 1999 Mar; 256(3):626-30. PubMed ID: 10080949
[TBL] [Abstract][Full Text] [Related]
26. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.
Boulton TG; Zhong Z; Wen Z; Darnell JE; Stahl N; Yancopoulos GD
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6915-9. PubMed ID: 7624343
[TBL] [Abstract][Full Text] [Related]
27. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
28. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
29. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
[TBL] [Abstract][Full Text] [Related]
30. The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway.
Abe K; Hirai M; Mizuno K; Higashi N; Sekimoto T; Miki T; Hirano T; Nakajima K
Oncogene; 2001 Jun; 20(27):3464-74. PubMed ID: 11429693
[TBL] [Abstract][Full Text] [Related]
31. Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes.
Fujio Y; Matsuda T; Oshima Y; Maeda M; Mohri T; Ito T; Takatani T; Hirata M; Nakaoka Y; Kimura R; Kishimoto T; Azuma J
FEBS Lett; 2004 Aug; 573(1-3):202-6. PubMed ID: 15327998
[TBL] [Abstract][Full Text] [Related]
32. [gp130F759 mouse].
Ishihara K; Hirano T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():68-72. PubMed ID: 15799320
[No Abstract] [Full Text] [Related]
33. Functional characterization of W147A: a high-affinity interleukin-11 antagonist.
Underhill-Day N; McGovern LA; Karpovich N; Mardon HJ; Barton VA; Heath JK
Endocrinology; 2003 Aug; 144(8):3406-14. PubMed ID: 12865319
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
[TBL] [Abstract][Full Text] [Related]
35. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Hirano T; Ishihara K; Hibi M
Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
[TBL] [Abstract][Full Text] [Related]
36. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
[TBL] [Abstract][Full Text] [Related]
37. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
Fairlie WD; De Souza D; Nicola NA; Baca M
Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
[TBL] [Abstract][Full Text] [Related]
38. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.
Fukada T; Hibi M; Yamanaka Y; Takahashi-Tezuka M; Fujitani Y; Yamaguchi T; Nakajima K; Hirano T
Immunity; 1996 Nov; 5(5):449-60. PubMed ID: 8934572
[TBL] [Abstract][Full Text] [Related]
39. Joint disease caused by defective gp130-mediated STAT signaling.
Naka T; Kishimoto T
Arthritis Res; 2002; 4(3):154-6. PubMed ID: 12010564
[TBL] [Abstract][Full Text] [Related]
40. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.
Haan C; Heinrich PC; Behrmann I
Biochem J; 2002 Jan; 361(Pt 1):105-11. PubMed ID: 11742534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
